Watson gains FDA approval for generic Plan B

06/24/2009 | Wall Street Journal, The

Watson Pharmaceuticals' generic version of the Plan B morning-after contraceptive pill received FDA approval for women 18 and older. The company plans to launch the nonprescription drug Aug. 24, when Duramed Pharmaceuticals' market exclusivity for Plan B expires. The generic version will be available for women 17 and younger by prescription only.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID